Metsera’s amylin drug shows early potential for substantial weight loss

statnews.com/2025/06/09/metsera-amylin-drug-shows-early-potential-for-substantial-weight-loss

Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial and the potential to have longer-lasting effects than current weight loss treatments on the market that are injected weekly.
In one part of a Phase 1 trial where patients received a…

This story appeared on statnews.com, 2025-06-09 15:39:36.780000.
The Entire Business World on a Single Page. Free to Use →